Completed PHASE4 INTERVENTIONAL 2-arm NCT00620893

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).

Sponsor: Bp Consulting, Inc

Interventions PEG- 400 based artificial tear Systane

Updated 5 times since 2017 Last updated: Sep 17, 2009 Started: Feb 29, 2008 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Dry Eye Syndromes, this trial is completed. The trial is conducted by Bp Consulting, Inc and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bp Consulting, Inc

Data source: Bp Consulting, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States